Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Knight Therapeutics Inc KHTRF


Primary Symbol: T.GUD

Healthcare
Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select... see more

Bullboard (TSX:GUD)

View:
Prev ... 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 ... Next
Comment by MrMugsyon Aug 14, 2022 5:45pm

RE:Last target was around 7,50$,

There is a sense of pride with going to market at INCREASED valuations.  They want to be able to say that ... if at all possible. Therefore, I would not look at $10 as an entry point for issuing ...more  
179
Discussion
Post by sylvain_007on Aug 14, 2022 7:10am

Last target was around 7,50$,

People spoke about 10$ if GUD return on the finance market. Short term, probably 7$ is possible.
243
Discussion
Comment by MrMugsyon Aug 13, 2022 1:48pm

RE:RE:RE:More than 55 million people Worldwide with dementia

Knowing how GUD is very careful as to how much they pay - I think it's hard to really know what they are thinking, how they feel growth will evolve for Exelon or what kind of advantage they have ...more  
183
Discussion
Comment by curiousjon Aug 13, 2022 12:30pm

RE:RE:More than 55 million people Worldwide with dementia

How would you justfiy the purchase of Exelon at over 3x and just below 4x EV/Sales for a generic given the high likelihood that Novartis has already maximized sales in Latam? On top of that, Novartis ...more  
160
Discussion
Comment by curiousjon Aug 13, 2022 12:21pm

RE:RE:Knights Loans

any news on synergy as a going concern? loan repmt doesn't seem promising
118
Discussion
Comment by MrMugsyon Aug 13, 2022 11:41am

RE:More than 55 million people Worldwide with dementia

GUD has two potential paths to AD at this time ... 1.  EXELON (now) 2.  future drug developments though existing/future partners  -------- I am very much a believer that AD is being ...more  
148
Discussion
Comment by MrMugsyon Aug 13, 2022 11:19am

RE:Knights Loans

I think they would still entertain loans but Samira is interested in real collateral (e.g. Samira wasn't interested in the Appili deal for that reason but Loadzone Holdings was). As a one-stop ...more  
159
Discussion
Comment by MrMugsyon Aug 13, 2022 11:14am

RE:so not all agreements are created equal...

Each deal likely has a value on it's own depending on expected sales and potential mark-up.  Assuming. Licenses are likely from the time of signing and they renegotiated at a certain point.& ...more  
156
Discussion
Comment by curiousjon Aug 13, 2022 10:57am

RE:so not all agreements are created equal...

*PS I meant for the "former" not latter in the text above
110
Discussion
Post by curiousjon Aug 13, 2022 10:55am

so not all agreements are created equal...

one key distinction I made about recent licensing deals are distribution vs license exclusivities, whereby the latter is holds no IP rights and is likely lower margin and the sponsor in this case ...more  
201
Discussion
Post by EbbFlow88on Aug 12, 2022 12:02pm

Knights Loans

I can't remember but I think the number of loans has decreased. Seems like they have been letting them run off and not renewing.  The Synergy loan is maturing in 2022 and 60 degree pharma ...more  
316
Discussion
Post by GoldenInvestoron Aug 12, 2022 10:57am

More than 55 million people Worldwide with dementia

Fitting stat just heard on the news  
256
Discussion
Post by sylvain_007on Aug 12, 2022 9:52am

volume is better now, will see 6$ and more

  So it's time, the health sector is turning UP so Gud willm follow the trend.
147
Prev ... 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 ... Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities